Polano, M.; Chierici, M.; Dal Bo, M.; Gentilini, D.; Di Cintio, F.; Baboci, L.; Gibbs, D.L.; Furlanello, C.; Toffoli, G.
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning. Cancers 2019, 11, 1562.
https://doi.org/10.3390/cancers11101562
AMA Style
Polano M, Chierici M, Dal Bo M, Gentilini D, Di Cintio F, Baboci L, Gibbs DL, Furlanello C, Toffoli G.
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning. Cancers. 2019; 11(10):1562.
https://doi.org/10.3390/cancers11101562
Chicago/Turabian Style
Polano, Maurizio, Marco Chierici, Michele Dal Bo, Davide Gentilini, Federica Di Cintio, Lorena Baboci, David L. Gibbs, Cesare Furlanello, and Giuseppe Toffoli.
2019. "A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning" Cancers 11, no. 10: 1562.
https://doi.org/10.3390/cancers11101562
APA Style
Polano, M., Chierici, M., Dal Bo, M., Gentilini, D., Di Cintio, F., Baboci, L., Gibbs, D. L., Furlanello, C., & Toffoli, G.
(2019). A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning. Cancers, 11(10), 1562.
https://doi.org/10.3390/cancers11101562